+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravascular Catheter Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 111 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4896242

The intravascular catheter market will show rapid growth due to the increasing cases of cardiovascular diseases and urological diseases, rapid improvement in intravascular catheter technology and the increasing number of catheterization labs.

There is an increasing prevalence of cardiovascular, neurological, oncological, urological and the other gastroenterological diseases. The rising cases of these diseases require the usage of catheters for the surgeries and diagnosis that helps in boosting the global intravascular catheters market growth. Moreover, the increase in the trauma injuries is also found stimulating the market growth. Additionally, urinary bladder related diseases, the prevalence of kidney failure, and other urological conditions are also some other factors propelling the growth of intravascular catheters.

Furthermore the rapid improvement in intravascular catheter technology development has enabled the adoption of these devices. The technology development has led to the reduction of bleeding complications, simplification of complex interventions, and expedition of routine procedures. Therefore these advantages has helped in the growth of the market.

Key Market Trends

Short Peripheral Intravascular Catheters (PIVC) are Expected to Dominate the Product Segment of the Intravascular Catheters Market During the Forecast Period

Short Peripheral Intravascular Catheters (PIVC) has dominated the market on account of the lower infection risk associated with these products. In addition, short PIVCs are mostly preferred over other catheters due to their quick discharge and short dwelling time.

According to the American Heart Association, cardiovascular disease (CVD), listed as the underlying cause of death, accounted for 840,678 deaths in the US in 2016, approximately 1 of every 3 deaths. In 2016, Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease in the US, followed by stroke (16.9%), High Blood Pressure (9.8%), Heart Failure (9.3%), diseases of the arteries (3.0%), and other cardiovascular diseases (17.7%).

Therefore the factors such as increasing prevalence of cardiovascular, neurological, oncological, and gastroenterological diseases are anticipated to drive the demand for PIVC in surgical intervention and diagnostics.

Asia Pacific is Found to be the Fastest Growing Segment of the Intravascular Catheters Market

Asia Pacific has been the fastest growing segment owing to the increasing investments in healthcare infrastructure, growing insurance coverage, and availability of reimbursements. There is also a growing prevalence of oncological disorders, infectious and renal diseases, and other urological problems and rising inpatient and emergency room procedures that helps in increasing the use of intravascular catheters. The North America region is expected to dominate the overall market.

Competitive Landscape

The market is highly competitive and comprises many players engaged in activities such as research and product development, medical device manufacturing, raw material supply, sales and distribution, and many other services. Therefore there is an increase in the number of companies investing in emerging nations that drives the market growth in such regions. The market is also influenced by ongoing mergers and acquisition across key players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Cases of Cardiovascular Diseases and Urological Diseases?
4.2.2 Rapid Improvement in Intravascular Catheter Technology?
4.2.3 Increasing Number of Catheterization Labs
4.3 Market Restraints
4.3.1 Side-effects Associated with the Catheters?
4.3.2 Low Penetration of Reimbursement
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Short Peripheral Intravascular Catheters (PIVC)
5.1.2 Integrated/Closed PIVC
5.2 By Application
5.2.1 Oncology
5.2.2 Gastroenterology
5.2.3 Renal Disease
5.2.4 Infectious Diseases
5.2.5 Other Diseases
5.3 By End User
5.3.1 Hospitals & Clinics
5.3.2 Ambulatory Surgical Centers
5.3.3 Homecare Setting
5.3.4 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 C.R. Bard Inc.
6.1.3 Medline Industries, Inc
6.1.4 Cook Medical
6.1.5 Edwards Life Sciences Corporation
6.1.6 Johnson & Johnson
6.1.7 McKesson Corporation
6.1.8 Medtronic PLC
6.1.9 Smiths Medical
6.1.10 Terumo Corporation

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boston Scientific Corporation
  • C.R. Bard Inc.
  • Medline Industries, Inc
  • Cook Medical
  • Edwards Life Sciences Corporation
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic PLC
  • Smiths Medical
  • Terumo Corporation